Outcome of surgery for oesophageal carcinoma in a low volume centre, with and without preoperative chemoradiotherapy

Scandinavian Journal of Surgery

Volumn 93, Issue 1, 2004, Pages 37-42

  Victorzon, Mikael ^a   Tolonen, P ^a   Kohonen, M ^a   Salmo, M ^a  

^a VAASA CENTRAL HOSPITAL   (Finland)

Author keywords

Chemoradiotherapy; Low volume centre; Neoadjuvant treatment; Oesophageal carcinoma, adenocarcinoma; Squamocellular carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; HYDROXYUREA;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; ESOPHAGUS SURGERY; FEMALE; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PATIENT REFERRAL; PREOPERATIVE CARE; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 1942469469     PISSN: 14574969     EISSN: None     Source Type: Journal    
DOI: 10.1177/145749690409300108     Document Type: Article

References (33)

1. Siewert JR, Fink U, Beckurts KTE, Roder JD: Surgery of squamous cell carcinoma of the esophagus. Ann Oncol 1994;5: (Suppl 3):1-7
2. Ilson DH, Kelsen D: Combined modality in the treatment of esophageal cancer. Semin Oncol 1994;21:493-507
3. Sihvo E, Salminen J, Ramo O, Salo J: The epidemiology of esophageal adenocarcinoma: has the cancer of gastric cardia an influence on the rising incidence of oesophageal adenocarcinoma? Scand J Gastroent 2000;35:1082-1086
4. Lund O, Hasenkam JM, Aagaard MT, Kimose HH: Time-related changes in characteristics of prognostic significance in carcinomas of the oesophagus and cardia. Br J Surg 1989;76: 1301-1307
5. Papachristou DN, Fortner JG: Adenocarcinoma of the gastric cardia: the choice of gastrectomy. Ann Surg 1980;192:58-64
6. Roder JD, Busch R, Stein HJ, Fink U, Siewert JR: Ratio of invaded to removed lymph nodes as a predictor of survival in squamous cell carcinoma of the oesophagus. Br J Surg 1994; 81:410-413
7. Urba SG, Orringer MB, Turrisi A, Lannettoni M, Forastiere A, Strawderman M: Randomised trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol 2001;19:305-313
8. Medical Research Council Oesophageal Cancer Working Party: Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet 2002;359:1727-1733
9. Kelsen DP, Ginsberg R, Pajak TF, Sheahan DG, Gunderson L, Mortimer J, Estes N, Haller DG, Ajani J, Kocha W, Minsky BD, Roth JA: Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med 1998;339:1979-1984
10. Bosset J-F, Gignoux M, Triboulet J-P, Tiret E, Mantion G, Elias D, Lozach P, Ollier J-C, Pavy J-J, Mercier M, Sahmoud T: Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med 1997;337:161-167
11. Adelstein D, Rice TW, Boyce GA, Sivak MV, Van Kirk MA, Kirby TJ, Van Stolk RU, Bukowski RM: Adenocarcinoma of the esophagus and gastroesophageal junction: clinical and pathological assessment of respons to induction chemotherapy. Am J Clin Oncol 1994;17:114-118
12. Stewart JR, Hoff SJ, Johnson DH, Murray MJ, Butler DR, Elkins CC, Sharp KW, Merrill WH, Sawyers JL: Improved survival with neoadjuvant therapy and resection for adenocarcinoma of the esophagus. Ann Surg 1993;218:571-576
13. Coia LR, Paul AR, Engstrom PF: Combined radiation and chemotherapy as primary management of adenocarcinoma of the esophagus and gastroesophageal junction. Cancer 1988; 61:643-649
14. Walsh TN, Noonan N, Hollywoood D, Kelley A, Keeling N, Hennessy TPJ: A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med 1996; 335:462-467
15. Ganem G, Dubray B, Raoul Y, Colin P, Bardet E, Douilllard J-Y, Goudier M-J, Hennequin C, Walter S, Michel-Langlet P, Martin P, Maron D, Morvan F, Andolenko P, Extra J-M: Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagus. J Clin Oncol 1997;15:701-711
16. UICC: TNM classification of malignant tumours. Ed 5 Wiley-Liss New York 1997
17. Wayman J, Dresner S, Raimes S, Griffin S: Transhiatal approach to total gastrectomy for adenocarcinoma of the gastric cardia. Br J Surg 1999;86:536-540
18. El Nakadi I, Van Laethem J, Houben J, Gay F, Closset J, Van Houtte P, Danhier S, Limbosch J, Lambilliotte J, Gelin M: Squamous cell carcinoma of the esophagus: Multimodal Therapy in locally advanced disease. World J Surg 2002;26:72-78
19. Goldfaden D, Orringer M, Appelman H, Kalish R: Adenocarcinoma of the distal esophagus and gastric cardia. Comparison of results of transhiatal esophagectomy and thoracoabdominal esophagogastrectomy. J Thorac Cardiovasc Surg 1986;91:242-247
20. Parshad R, Singh R, Kumar A, Gupta S, Chattopadhyay T: Adenocarcinoma of distal esophagus and gastroesophageal junction: long-term results of surgical treatment in a North Indian center. World J Surg 1999;23:277-283
21. Hulscher JBF, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, Stalmeier PF, ten Kate FJ, van Dekken H, Obertop H, Tilanus HW, van Lanschot JJ: Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med 2002; 347:1662-1669
22. Makary MA, Kiernan PD, Sheridan MJ, Tonnesen G, Hetrick V, Vaughan B, Graling P, Elster E: Multimodality treatment for esophageal cancer: The role of surgery and neoadjuvant theapy. Am Surg 2003;69:693-700
23. Boyle MJ, Franceschi D, Livingstone AS: Transhiatal versus transthoracal esophagectomy: Complication and survival rates. Am Surg 1999;65:1137-1141
24. Slater MS, Holland J, Faigel DO, Sheppard BC, Deveney CW: Does neoadjuvant chemoradiation downstage esophageal carcinoma? Am J Surg 2001;181:440-444
25. Birkmeyer JD, Siewers AE, Finlayson EVA, Stukel TA, Lucas FL, Batista I, Welch HG, Wennberg DE: Hospital volume and surgical mortality in the United States. N Engl J Med 2002;346: 1128-1137
26. Altorki N, Kent M, Ferrara C, Port J: Three-field lymph node dissection for squamous-cell and adenocarcinoma of the esophagus. Ann Surg 2002;236:177-183
27. Al-Sarraf M, Martz K, Herskovic A, Leichman L, Brindle JS, Vaitkevicius VK, Cooper J, Byhardt R, Davis L, Emami B: Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 1997;15:277-284
28. Siewert JR, Feith MF, Werner M, Stein HJ: Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353-361
29. Mariette C, Castel B, Toursel H, Fabre S, Balon JM, Triboulet J-P: Surgical management of and long-term survival after adenocarcinoma of the cardia. Br J Surg 2002;89:1156-1163
30. Velanovich V, Hollingsworth J, Suresh P, Ben-Menachem T: Relationship of gastroesophageal reflux disease with adenocarcinoma of the distal esophagus and cardia. Dig Surg 2002; 19:349-353
31. Devesa SS, Blot WJ, Fraumeni JFJ: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049-2053
32. El-Serag HB, Sonnenberg A: Opposing time trends of peptic ulcer and reflux disease. Gut 1998;43:327-333
33. Protocol 40001: Randomised study of pre-operative radiochemotherapy versus surgery alone in thoracic oesophageal cancer deemed to be resectable. www.eortc.be 2002